Part 2: Featured interview with BioPharm International
Designing an efficient clinical trial and identifying the right sites and patients for enrollment can be time-consuming, particularly when key information is spread across complex clinical data.
In this installment of ConcertAI’s four-part interview series with BioPharm International, Eron Kelly, CEO, and Shaalan Beg, MD, CMO of Oncology, discuss how AI reasoning models can help streamline clinical trial design by digitizing eligibility criteria, comparing proposed studies with similar trials, and identifying relevant trial attributes in minutes rather than weeks.
They also explore how AI can help sponsors assess patient populations within the current standard of care, identify sites with relevant historical patient populations, and accelerate enrollment—while emphasizing the importance of validating AI-generated insights for accuracy, clinical coherence, and biological relevance.
Watch the interview to learn how AI can help advance more efficient, data-driven clinical research.